Effects of Celecoxib After Percutaneous Coronary Intervention

NCT00292721 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Coronary Arteriosclerosis

Interventions

DRUG: Celecoxib

Sponsor

Seoul National University Hospital